Advertisement

Reactions Weekly

, Volume 1766, Issue 1, pp 192–192 | Cite as

Mepolizumab/omalizumab

Infusion reaction following an off-label use: 2 case reports
Case report
  • 14 Downloads

Reference

  1. Canzian A, et al. Off-Label use of biological therapies in relapsing and/or refractory eosinophilic granulomatosis with polyangiitis (churg-strauss). Annals of the Rheumatic Diseases 78 (Suppl. 2): 820 (plus poster) abstr. FRI0278, Jun 2019. Available from: URL: http://doi.org/10.1136/annrheumdis-2019-eular.6243 [abstract] - Italy

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations